2026 NPPES data Ophthalmology Physician NPI 1366484479 MD
Verify on CMS →

JOHN GILLESPIE, MD

Ophthalmology Physician in RUSSELLVILLE, Arkansas. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
579
Medicare Part D claims · 125 beneficiaries · Ophthalmology Physician avg: 1K
Generic prescribing
64%
generic claims · 36% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$58.42
1 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

JOHN GILLESPIE, MD filed 579 Medicare Part D claims in 2023 as a Ophthalmology Physician in RUSSELLVILLE, Arkansas, prescribing 64% generic.

579
Part D claims, 2023
64%
generic prescribing
$58.42
industry payments (Sunshine Act)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

JOHN GILLESPIE, MD's Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

579 Top 34% higher than 66% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). Below this entry. 200–400: 182,923 prescribers (13%). Below this entry. 400–600: 90,619 prescribers (7%). This entry sits in this band. 600–800: 56,224 prescribers (4%). Above this entry. 800–1,000: 40,919 prescribers (3%). Above this entry. 1,000–1,200: 31,827 prescribers (2%). Above this entry. 1,200–1,400: 26,224 prescribers (2%). Above this entry. 1,400–1,600: 21,710 prescribers (2%). Above this entry. 1,600–1,800: 19,072 prescribers (1%). Above this entry. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2,000–2,200: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

Board-eligible specialty (heuristic — not verified)

JOHN GILLESPIE, MD practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about JOHN GILLESPIE, MD?

Quality data not reported

NPI registry status

Active

Issued 06/12/2006

NPI 1366484479

Primary specialty

Ophthalmology Physician

Mid-sized

22,090 US NPIs in this specialty

Medicare Part D claims

579 59% vs specialty avg

2023 prescription claims

Specialty avg: 1,420

Specialty distribution in Arkansas

How Ophthalmology Physician compares to other specialties among Arkansas providers

Arkansas providers

Ophthalmology Physician share within Arkansas

1. Ophthalmology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Ophthalmology Physician share within Arkansas

Specialty board-certification context

Estimated specialty board-certified rate — Ophthalmology Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Ophthalmology Physician ABMS/AOA estimate

Est. board-certified rate (Ophthalmology Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Ophthalmology Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

JOHN GILLESPIE, MD appears in the CMS NPPES registry as a Ophthalmology Physician provider holding MD credentials at 2711 E PARKWAY DR, RUSSELLVILLE, AR, 72802, with a listed phone of (479) 968-7302. NPI 1366484479 was issued on 06/12/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what GILLESPIE most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 579 prescription claims written by this provider, covering 125 Medicare beneficiaries and totaling roughly $91K in drug spend, split 36% brand-name and 64% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Ophthalmology Physician is a mid-sized specialty nationwide, with 22,090 enrolled providers across 56 states and an average of 1,420 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

2711 E PARKWAY DR
RUSSELLVILLE, AR 72802

Provider Details

NPI 1366484479
Specialty Ophthalmology Physician
Credentials MD
Gender Male
NPI Issued 06/12/2006

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for JOHN GILLESPIE, MD. Source: openpaymentsdata.cms.gov.

Total received

$58

Largest payer

BIOTISSUE HOLDINGS INC.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

Brand vs generic prescribing mix · Above average

JOHN GILLESPIE, MD — brand share 36.0%
Specialty average (est.)

36% brand-name claims vs 64% generic, on 579 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

579
Total Claims
$91K
Total Drug Cost
125
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
1,162
Total Day Supply
34,330
Brand vs Generic
36% brand / 64% generic
Brand Drug Cost
$71K
Generic Drug Cost
$20K

Patient Demographics

Average Patient Age
74.6 years
Avg HCC Risk Score
1.35
Gender Split
60% female / 40% male
Age Distribution
<65: 18, 65-74: 37, 75-84: 41, 85+: 29

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What JOHN GILLESPIE, MD prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Latanoprost
208
Dorzolamide-Timolol
Dorzolamide Hcl/Timolol Maleat
91
Brimonidine Tartrate
43
Restasis
Cyclosporine
42
Timolol Maleate
36
Travoprost
27
Simbrinza
Brinzolamide/Brimonidine Tart
17
Erythromycin
Erythromycin Base
14
Lumigan
Bimatoprost
14
Dorzolamide Hcl
12

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Ophthalmology Physician Overview

How JOHN GILLESPIE, MD fits within the Ophthalmology Physician landscape nationally.

22,090
Ophthalmology Physician Providers in US
56
States with Ophthalmology Physician
1,420
Avg Claims per Provider

JOHN GILLESPIE, MD's 579 claims are below the specialty average of 1,420.

Nearby Ophthalmology Physician Providers in Arkansas

Other clinicians with the same primary specialty enrolled in Arkansas, drawn from the same CMS NPPES roster as GILLESPIE.

Compare Ophthalmology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is JOHN GILLESPIE, MD's specialty?
JOHN GILLESPIE, MD specializes in Ophthalmology Physician and practices in RUSSELLVILLE, Arkansas. Credentials: MD.
How much does JOHN GILLESPIE, MD prescribe under Medicare Part D?
In 2023, JOHN GILLESPIE, MD wrote 579 Medicare Part D claims totaling $91K in drug costs for 125 beneficiaries.
Where is JOHN GILLESPIE, MD located?
JOHN GILLESPIE, MD is located at 2711 E PARKWAY DR, RUSSELLVILLE, AR, 72802. Phone: (479) 968-7302.
What is JOHN GILLESPIE, MD's NPI number?
JOHN GILLESPIE, MD's National Provider Identifier (NPI) is 1366484479, issued on 06/12/2006.
Does JOHN GILLESPIE, MD prescribe more brand-name or generic drugs?
JOHN GILLESPIE, MD's prescribing is 36% brand-name and 64% generic drugs by claim count, with $71K in brand drug costs.
How many Ophthalmology Physician providers are there in the US?
There are 22,090 Ophthalmology Physician providers across 56 states in the US. The average Ophthalmology Physician provider writes 1,420 Medicare Part D claims per year.
What drugs does JOHN GILLESPIE, MD prescribe most often?
Based on 2023 Medicare Part D data, JOHN GILLESPIE, MD's most frequently prescribed drugs include Latanoprost, Dorzolamide-Timolol, Brimonidine Tartrate. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does JOHN GILLESPIE, MD accept Medicare?
JOHN GILLESPIE, MD appears in CMS Medicare data with 579 Part D claims and 125 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify JOHN GILLESPIE, MD's credentials?
JOHN GILLESPIE, MD's NPI is 1366484479 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology